XML 31 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Licensing revenue $ 850 $ 0
Research and development 42,342 38,120
General and administrative 15,133 12,243
Total operating expenses 57,475 50,363
Loss from operations (56,625) (50,363)
Other income 7,250 7,869
Net loss $ (49,375) $ (42,494)
Net loss per share - basic and diluted (in dollars per share) $ (0.36) $ (0.33)
Basic and diluted weighted average shares outstanding (in shares) 137,384 127,027
Other comprehensive loss:    
Net loss $ (49,375) $ (42,494)
Unrealized gain on marketable securities 173 339
Comprehensive loss $ (49,202) $ (42,155)